Cardiff Oncology, Inc. - Common Stock (CRDF)

CUSIP: 14147L108

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class
Equity / Common Stock
Shares outstanding
66,577,393
Total 13F shares
12,761,449
Share change
-435,554
Total reported value
$34,074,638
Put/Call ratio
11%
Price per share
$2.67
Number of holders
82
Value change
-$895,795
Number of buys
32
Number of sells
38

Quarterly Holders Quick Answers

What is CUSIP 14147L108?
CUSIP 14147L108 identifies CRDF - Cardiff Oncology, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Cardiff Oncology, Inc. - Common Stock (CRDF) as of Q3 2024

As of 30 Sep 2024, Cardiff Oncology, Inc. - Common Stock (CRDF) was held by 82 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 12,761,449 shares. The largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, MAI Capital Management, RENAISSANCE TECHNOLOGIES LLC, MORGAN STANLEY, Nuveen Asset Management, LLC, TWO SIGMA ADVISERS, LP, and NORTHERN TRUST CORP. This page lists 82 institutional shareholders reporting positions in this security for the Q3 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.